School of Medicine
Showing 701-800 of 890 Results
-
Michael Loecher
Physical Science Research Scientist, Rad/Radiological Sciences Laboratory
BioMy research focuses primarily on improving methods for measuring flow and motion with MRI. My research interests range from image acquisition and reconstruction to error correction and post processing strategies.
-
Andreas Loening
Assistant Professor of Radiology (Body MRI)
Current Research and Scholarly InterestsMy lab focuses on expanding the capability of MR and PET/MR as it relates to applications in body imaging. Clinical research aims include the application of new or improved MR sequences to increase the speed, robustness, and diagnostic capability of body MR. Translation research aims include exploring new MR contrast mechanisms and contrast agents, such as for the stratification of cancer within the prostate and the evaluation of the lymphatic system.
-
Juanita S. Loftus
Clinical Instructor, Pediatrics - General Pediatrics
BioClinical Focus
____
Pediatrics
Academic Appointment
____
Clinical Instructor, General Pediatrics
Professional Education
_____
Board Certification: American Board of Pediatrics, Pediatrics (1989)
Residency: St. Louis Children's Hospital, St. Louis, MO (1989)
Medical Education: Washington University School of Medicine, St. Louis, MO (1986) -
Daniel S Logan
Research Data Analyst 1, Stanford-Surgery Policy Improvement Research and Education Center
BioDaniel Logan is a Research Data Analyst with the Stanford-Surgery Policy Improvement Research & Education Center (S-SPIRE). Daniel obtained a bachelors degree in Sociology from Bates College as well as a bootcamp diploma in Data Science. He has experience with a variety quantitative and qualitative research methodologies, making him unique situated for mixed methods research. As a research data analyst, he puts this background to use for machine learning optimization, data management, and general analytics for clinical and observational studies.
-
Kyle Loh
Assistant Professor of Developmental Biology (Stem Cell)
BioHow the richly varied cell-types in the human body arise from one embryonic cell is a biological marvel and mystery. We have mapped how human embryonic stem cells develop into over twenty different human cell-types. This roadmap allowed us to generate enriched populations of human liver, bone, heart and blood vessel precursors in a Petri dish from embryonic stem cells. Each of these tissue precursors could regenerate their cognate tissue upon injection into respective mouse models, with relevance to regenerative medicine. In addition to our interests in developmental and stem cell biology, we also interested in discovering the entry receptors and target cells of deadly biosafety level 4 viruses, together with our collaborators.
Kyle attended the County College of Morris and Rutgers University, and received his Ph.D. from Stanford University (working with Irving Weissman), with fellowships from the Hertz Foundation, National Science Foundation and Davidson Institute for Talent Development. He then continued as a Siebel Investigator, and later, as an Assistant Professor and The Anthony DiGenova Endowed Faculty Scholar at Stanford, where he is jointly appointed in the Department of Developmental Biology and Institute for Stem Cell Biology & Regenerative Medicine. Kyle is a Packard Fellow, Pew Scholar, Human Frontier Science Program Young Investigator and Baxter Foundation Faculty Scholar, and his research has been recognized by the NIH Director's Early Independence Award, Forbes 30 Under 30, Harold Weintraub Graduate Award, Hertz Foundation Thesis Prize and A*STAR Investigatorship. -
Martin J. Lohse
Visiting Professor, Molecular & Cellular Physiology
BioMartin Lohse studied medicine and philosophy at the universities of Göttingen (Germany), London (UK) and Paris (France). From 1978 to 1981 he did his MD thesis in the Department of Neurobiology at the Max Planck Institute of Biophysical Chemistry with Otto Creutzfeldt and Wolfgang Wuttke investigating the central nervous system effects of endogenous opiates. He was a postdoc in pharmacology with Ulrich Schwabe at the University of Heidelberg, and then with Robert J. Lefkowitz (HHMI, Duke University), where he later became an Assistant Professor. From Duke he moved to his first independent lab at the Gene Center in Munich/Martinsried, a new research center operated jointly by the Max Planck Institute for Biochemistry and the University of Munich. In 1993, he became Chair of the Institute of Pharmacology and Toxicology at the University of Würzburg, and remained a professor at this university until his retirement in 2022. In Würzburg, he founded the Rudolf Virchow Center, the DFG Research Center for Experimental Biomedicine (2001-2016), and he became also the founding director of the University of Würzburg Graduate School (2003-2016).
From 2016 to 2019 he served as Chairman of the Max Delbrück Center in Berlin, a national research center for molecular medicine. In 2020, while keeping his lab in Berlin, he moved back to Bavaria to establish and lead the new start-up institute/incubator ISAR Bioscience in Munich/Planegg, that aims to use stem cell technologies to advance academic projects towards clinical applications and to foster the formation of start-up companies.
Martin Lohse has accepted many public and professional service duties. He was a member of the German National Ethics Council, Vice President for Research of the University of Würzburg, Vice President of the German National Academy of Sciences Leopoldina, and President of the Society of German Natural Scientists and Physicians GDNÄ. He has been a member and chair of numerous scientific advisory boards across Europe. He holds honorary, senior and distinguished professorships at the Free University of Berlin, the University of Leipzig, and the Technical University of Munich TUM. At the Department for Molecular and Cellular Physiology of Stanford University he collaborates with the teams of Brian Kobilka and Ruth Hüttenhain to probe the local environment of receptors and its function and regulation. -
Renske Lok
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsI'm interested in questions regarding perceived experiences and measured markers of those experiences, for example how do perceived sleep quality relate to sleep quality measured, or how does daytime sleepiness relate to sleep quality at night.
Other interests include effects of daytime light exposure on nighttime sleep, circadian clock phase changes by flashes of light, and how stability and variability in daily rhythms can predict health and disease -
Adrienne H. Long, MD, PhD
Instructor, Pediatrics - Hematology & Oncology
BioAdrienne H. Long, MD, PhD is an instructor in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital at Stanford. Dr. Long attend Northwestern University, where she earned both her BS in biomedical engineering and her MD. Determined to help develop novel treatments for pediatric cancer patients, she took time during medical school to pursue a PhD at the National Institutes of Health (NIH), where she helped advance CAR T cell therapies with Dr. Crystal Mackall. Her influential thesis work was the first to identify T cell exhaustion as a critical factor limiting efficacy of CAR therapies (Long et al., Nature Medicine, 2015), and also identified novel methods to enhance CAR therapies for pediatric solid tumor patients (Long/Highfill et al., Cancer Immunology Research, 2016). Dr. Long went on to complete her pediatrics residency training at Boston Children’s Hospital, where she continued her research in cancer immunology with Dr. Nicholas Haining – this time focusing on strategies to enhance antigen presentation to augment checkpoint blockade (Long et al. Keystone Symposium on Cancer Immunotherapy, 2019). She completed her pediatric oncology fellowship at Stanford, and remains dedicated to a career as a physician-scientist focused on developing novel immunotherapies for children with cancer. She is currently conducting her post-doctoral research with Dr. Mark Davis, studying how thymic selection, designed to prevent auto-immunity, may also inhibit antitumor immunity in children.
-
Jonathan Z. Long
Associate Professor of Pathology
BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies signaling pathways in mammalian energy metabolism. The long-term goal of this program is to discover new molecules and pathways that can be translated into therapeutic opportunities for obesity, metabolic disease, and other age-associated chronic diseases. Work from the laboratory has been recognized by numerous awards from the Alfred P. Sloan Foundation, the National Institutes of Health, the American Diabetes Association, and the Ono Pharma Foundation. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.
-
Sharon R. Long
William C. Steere, Jr. - Pfizer Inc. Professor of Biological Sciences and Professor, by courtesy, of Biochemistry
Current Research and Scholarly InterestsBiochemistry, genetics and cell biology of plant-bacterial symbiosis
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
On Leave from 09/01/2023 To 05/16/2024Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Dr. Michael T. Longaker
Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Current Research and Scholarly InterestsWe have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.
-
Frank M. Longo, MD, PhD
George E. and Lucy Becker Professor of Medicine and Professor, by courtesy, of Neurosurgery
On Leave from 11/01/2023Current Research and Scholarly InterestsClinical interests include Alzheimer's disease and Huntington's disease and the development of effective therapeutics for these disorders. Laboratory interests encompass the elucidation of signaling mechanisms relevant to neurodegenerative disorders and the development of novel small molecule approaches for the treatment of neurodegenerative and other neurological disorders.
-
James Longoria, MD
Clinical Associate Professor, Cardiothoracic Surgery
BioDr. Longoria is a board-certified, fellowship-trained cardiothoracic surgeon. He is a clinical associate professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
Deeply accomplished in all facets of complex adult cardiothoracic procedures, Dr. Longoria is a high-volume surgeon with more than 20 years of experience and an exceptionally low mortality and complication rate.
Dr. Longoria’s surgical experience includes complex mitral valve and tricuspid valve repair, coronary artery bypass grafting, adult congenital repair, as well as procedures for high risk VAD patients. He performs cardiac transplantation, carotid endarterectomy, and implantation of all FDA-approved mechanical circulatory support devices. Additionally, he performs catheter-based valvular procedures (such as transcatheter aortic valve replacement, or TAVR) and open and video-assisted thoracoscopic surgery (VATS) for pulmonary surgical procedures.
He has an applied interest in atrial fibrillation (AFib) and is a nationally recognized expert in the minimally invasive surgical treatment of Atrial Fibrillation (AFib). Dr. Longoria was issued a method patent from the U.S. Patent and Trademark Office for developing the TTMaze (Totally Thoracoscopic) procedure that is central to the Dual Epicardial Endocardial Persistent (DEEP) AFib clinical trial.
Before joining Stanford, Dr. Longoria was the surgical director of cardiac ablation at a prominent AFib center certified by the Society of Chest Pain Centers. He holds patents for a synthetic chord used to connect tissue and for specialized methods he developed to treat cardiac arrhythmias.
At Stanford, Dr. Longoria brings a commitment to patientcentric, personalized care. He is committed to making the experience of surgery as pleasant as possible for his patients. He is also excited for the opportunity to conduct translational research that utilizes the most advanced technology available, in collaboration with colleagues from other disciplines.
For his outcomes and high patient satisfaction ratings, Dr. Longoria has earned awards and recognition, including being named a Top Doctor of Sacramento by his peers for the last five years in a row. He has also been an honoree of the President’s Award for patient satisfaction by the Sutter Independent Physicians.
Dr. Longoria has published articles on genetic variants associated with atrial fibrillation, thoracoscopic left atrial appendage clipping, radiofrequency ablation, and other topics. His work has appeared in the Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of the American College of Cardiology, Journal of Cardiovascular Electrophysiology, and elsewhere.
He has made numerous presentations on atrial fibrillation surgery and other topics at conferences including the Annual Meeting of the American Association of Thoracic Surgery, Society of Thoracic Surgeons, and International Society for Heart and Lung Transplantation.
Dr. Longoria is a Fellow of the American College of Surgeons and American College of Cardiology. He is a member of the Society of Thoracic Surgeons, Western Thoracic Surgical Association, the International Society for Minimally Invasive Cardiothoracic Surgery, and the Heart Rhythm Society. -
Billy W Loo, Jr, MD PhD FASTRO FACR
Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy clinical specialty is radiation treatment of thoracic cancers.
My research is on developing next-generation ultra-rapid radiation therapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.
My clinical research is on advanced 4-D image-guided radiation therapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers. -
Jaime Lopez, MD
Professor of Neurology (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy clinical interests are in the areas of Intraoperative Neurophysiologic Monitoring (IOM), clinical neurophysiology, electromyopgraphy and in the use of botulinum toxins in the treatment of neurologic disorders. Our IOM groups research is in the development of new and innovative techniques for monitoring the nervous system during surgical and endovascular procedures and how these alter surgical management and patient outcomes. I am also active in formulating national IOM practice guidelines.
-
Romain Lopez
Affiliate, Genetics
Visiting Postdoctoral Scholar, GeneticsBioSince Fall 2021, I am a joint postdoctoral scholar at Stanford University and Genentech Research and Early Development, hosted by Jonathan Pritchard and Aviv Regev. I recently obtained my PhD degree from the department of Electrical Engineering and Computer Sciences at UC Berkeley, advised by Mike Jordan & Nir Yosef. My research interests lie at the intersection of statistics, computation and modeling with a focus on biological applications.
A significant part of my research is driven by building more statistically accurate and faster machine learning software for analyzing single-cell omics data. I developed single-cell Variational Inference (scVI), a flexible model and a scalable inference method for comprehensive analysis of single-cell transcriptomes. I co-developed scvi-tools, an open-source software suite for fully-probabilistic modeling of single-cell multi-omics data. You may learn more about these topics in my guest lecture of the Deep Learning in the Life Sciences class at MIT.
More generally, I am interested in the broader area of ML + Science. Deep generative models provide an appealing and flexible paradigm for learning distributions, but quite some work is needed to fully exploit them as part of a scientific hypothesis testing pipeline (e.g., causality, interpretability, disentanglement, decision-making).
Previously, I worked on counterfactual inference and offline policy learning methods in collaboration with technology companies. In 2018, I visited Le Song at Ant Financial in Hangzhou. In 2019, I visited Inderjit Dhillon at Amazon in Berkeley. Before graduate school, I obtained a MSc in applied mathematics from Ecole polytechnique, Palaiseau in 2016. Additionally, I worked as an intern at the Harvard Medical School with Allon Klein in 2016. I was born and grew up in Bedarieux, France. -
H. Peter Lorenz, MD
Professor of Surgery (Plastic and Reconstructive Surgery)
Current Research and Scholarly InterestsWe have three areas of current investigation:
1) Scarless skin wound healing biology
2) Dot stem cell tissue regeneration biology
3) Novel stem cell therapy for tissue engineering -
Karl Lorenz
Professor of Medicine (Primary Care and Population Health)
BioDr. Karl Lorenz, MD MSHS is a general internal medicine and palliative care physician, and Section chief of the VA Palo Alto-Stanford Palliative Care Program. Formerly at the VA Greater Los Angeles, Dr. Lorenz directed palliative care research at the VA Center for Innovation to Implementation and served on the faculty at the UCLA School of Medicine. Dr. Lorenz is a member of the VA’s national Hospice and Palliative Care Program (HPC) leadership team, director of the operational palliative care Quality Improvement Resource Center (QuIRC), and adjunct facility staff member at RAND. Dr. Lorenz’s work and leadership has been influential to the field of palliative care research. Under Dr. Lorenz’s leadership, since 2009 the Quality Improvement Resource Center (QuIRC) has served as one of three national leadership Centers responsible for strategic and operational support of the VA’s national hospice and palliative care programs. QuIRC develops and implements provider facing electronic tools for the VA’s national electronic medical record to improve the quality of palliative care. In that role, Dr. Lorenz participates with the national leadership team in strategic planning, policy development, and providing resources to support operational efforts. Dr. Lorenz has contributed to the field of global palliative care, serving the World Health Organization in its development of Palliative Care for Older People and leading methods for Palliative Care Essential Medications.
-
Javier Lorenzo
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Javier Lorenzo is the Associate Division Chief of Anesthesia Critical Care in the Department of Anesthesia, Perioperative and Pain Medicine. He is also a Medical Informatics Director for the critical care areas and serves as Co-Chair of the Patient Safety Committee for Stanford HealthCare.
-
Irene L. Llorente
Assistant Professor of Neurosurgery
BioOriginally from Spain, Irene L. Llorente joined the Neurosurgery Department at Stanford University in 2022. Following her undergraduate degree in Molecular Biology at the University of Leon in Spain, Dr. Llorente completed a MS in Molecular Biology and Biomedicine and a Ph.D. in Neuroscience between the Universities of Leon (Spain) and Florence (Italy). She conducted a postdoctoral fellowship in the Neurology Department at the David Geffen School of Medicine at UCLA where she also started her independent career as a Research Assistant Professor. Her research interests are largely directed toward understanding the biology of white matter repair in central nervous system (CNS) disorders, with a special emphasis on human glial biology. She is particularly interested in leveraging the current technologies emerging in the stem cell field to develop more efficient and effective stem cell-based therapies for stroke and vascular dementia patients. These stem cell-based therapies will also apply to other CNS disorders including spinal cord injury, multiple sclerosis, and traumatic brain injury in the future.
-
Kate Lorig
Professor (Research) of Medicine (Immunology and Rheumatology), Emerita
Current Research and Scholarly InterestsCommunity based psycoeducational intervention studies of disease self management for people with chronic diseases. arthritis, lung diseases, heart disease AIDs, low back pain and diabetes. Programs and studies in Spanish and English. Interventions are in small groups, mailed or on the Internet.
-
Alan K. Louie, M.D., D.L.F.A.P.A.
Professor (Teaching) of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsMedical Education
-
John D. Louie, MD
Clinical Professor, Radiology
Current Research and Scholarly InterestsMy research interests focus on interventional oncology which include radioembolization (SIR Spheres and Theraspheres), chemoembolization, and ablation.
-
David Love
Strategy and Operations Lead, Technology & Digital Solutions
BioEverything should be as simple as it can be, but not simpler.
-- Albert Einstein (attributed)
It can scarcely be denied that the supreme goal of all theory is to make the irreducible basic elements as simple and as few as possible without having to surrender the adequate representation of a single datum of experience.
-- Albert Einstein (actual) -
Alarice Cheng-Yi Lowe
Associate Professor of Pathology
BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Anson Lowe
Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsThe laboratory is focused on the relationship between injury, wound healing, and cancer. Esophageal, gastric, and pancreatic cancers are a focus. We are particularly interested in the regulation of cell signaling by EGFR, the EGF receptor. In addition to cancer pathogenesis, active projects include the development of new diagnostic assays and drugs.
-
Chenery Lowe
Postdoctoral Scholar, Biomedical Ethics
BioChenery Lowe, Ph.D., CGC, is a genetic counselor and healthcare communication researcher. She received her ScM in Genetic Counseling from the Johns Hopkins University/ National Institutes of Health Genetic Counseling Training Program in 2018. Chenery received her Ph.D. in Social and Behavioral Sciences from Johns Hopkins Bloomberg School of Public Health in 2022, where she later served as an assistant scientist and academic director for the JHU/NIH genetic counseling program. Clinically, she has provided genetic counseling in immunology and adult oncology settings. She has taught graduate-level courses on interpersonal communication in health care, health literacy, and social and behavioral research in genetic counseling. Her research interests are in the areas of patient-provider communication, health equity, implicit bias, communication skills training interventions, and the ethics of interpersonal influence in medical care.
-
Henry J. Lowe, MD
Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy research in the field of biomedical informatics over the past 30 years has focused on the development of novel uses of information technology and computer science to improve human health. My current interests include the Electronic Health Record (EHR), biomedical knowledge representation, Internet applications in healthcare, clinical data warehouses, clinical data and text mining, academic social networking and the use of information technology to support clinical and translational research.
-
Jason Lowe
Clinical Associate Professor, Emergency Medicine
Clinical Assistant Professor, PediatricsCurrent Research and Scholarly InterestsUse of telemedicine to facilitate handoffs between disparate institutions.
Use of 360 video and virtual reality as a training medium.
Use of virtual reality and other tech platforms to distract pediatric patients from painful procedures. -
David Lowenberg, MD
Clinical Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Lowenberg is a Past President of the Limb Lengthening and Reconstruction Society of North America. His clinical and research interests are in the treatment of nonunions and malunions with or without accompanying osteomyelitis and infection. He is well-published in the field of limb salvage and treatment of devastating limb injuries. He has ongoing research in limb transplantation via immunotolerance as well as biomechanics.
-
Norman Lowenbraun
Member, Cardiovascular Institute
BioDr Lowenbraun has been a practicing cardiologist in the Bay Area for over 25 years, having moved here after receiving his medical and specialty training on the East Coast. He believes offering the personal care of a community setting and empowering the patient in their healthcare decisions, combined with the resources of Stanford Hospital , offers his patients the best of both worlds.
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.